Michael J. La Barre Halozyme Therapeutics, Inc. (HALO) insider trading activity

Michael J. La Barre is SVP, CHIEF TECHNICAL OFFICER of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 173,756 shares of HALO, which is worth approximately $10.1 Million. The most recent transaction as insider was on Apr 16, 2024, when has been sold 10,000 shares (Common Stock) at a price of $38.35 per share, resulting in proceeds of $383,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 174K

0% 3M change

2.76% 12M change

Total Value Held $10.1 Million

Michael J. LaBarre Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 16 2024	SELL Open market or private sale	$383,500 $38.35 p/Share	10,000 Reduced 5.61%	168,176 Common Stock
Apr 16 2024	BUY Exercise of conversion of derivative security	$81,100 $8.11 p/Share	10,000 Added 5.31%	178,176 Common Stock
Mar 26 2024	BUY Exercise of conversion of derivative security	$143,133 $12.32 p/Share	11,618 Added 6.46%	168,176 Common Stock
Mar 13 2024	SELL Open market or private sale	$422,700 $42.27 p/Share	10,000 Reduced 6.0%	156,558 Common Stock
Mar 13 2024	BUY Exercise of conversion of derivative security	$100,900 $10.09 p/Share	10,000 Added 5.66%	166,558 Common Stock
Mar 12 2024	SELL Open market or private sale	$416,400 $41.64 p/Share	10,000 Reduced 6.0%	156,558 Common Stock
Mar 12 2024	BUY Exercise of conversion of derivative security	$120,700 $12.07 p/Share	10,000 Added 5.66%	166,558 Common Stock
Feb 28 2024	SELL Open market or private sale	$395,500 $39.55 p/Share	10,000 Reduced 6.0%	156,558 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	$60,589 $8.11 p/Share	7,471 Added 4.36%	164,029 Common Stock
Feb 27 2024	SELL Open market or private sale	$399,500 $39.95 p/Share	10,000 Reduced 5.91%	159,087 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$189,777 $36.1 p/Share	5,257 Reduced 3.02%	169,087 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	10,376 Added 5.71%	171,247 Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$180,986 $35.91 p/Share	5,040 Reduced 2.98%	163,968 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	8,479 Added 4.81%	167,800 Common Stock
Feb 15 2024	BUY Exercise of conversion of derivative security	-	3,386 Added 2.07%	160,529 Common Stock
Feb 10 2024	SELL Payment of exercise price or tax liability	$102,956 $35.49 p/Share	2,901 Reduced 1.81%	157,143 Common Stock
Feb 10 2024	BUY Exercise of conversion of derivative security	-	8,133 Added 4.84%	160,044 Common Stock
Jan 17 2024	SELL Open market or private sale	$360,000 $36.0 p/Share	10,000 Reduced 6.18%	151,911 Common Stock
Jan 17 2024	BUY Exercise of conversion of derivative security	$120,700 $12.07 p/Share	10,000 Added 5.82%	161,911 Common Stock
Jan 16 2024	SELL Open market or private sale	$360,000 $36.0 p/Share	10,000 Reduced 6.18%	151,911 Common Stock
Jan 16 2024	BUY Exercise of conversion of derivative security	$120,700 $12.07 p/Share	10,000 Added 5.82%	161,911 Common Stock
Dec 13 2023	SELL Open market or private sale	$403,900 $40.39 p/Share	10,000 Reduced 6.18%	151,911 Common Stock
Dec 13 2023	BUY Exercise of conversion of derivative security	$120,700 $12.07 p/Share	10,000 Added 5.82%	161,911 Common Stock
Dec 12 2023	SELL Open market or private sale	$400,300 $40.03 p/Share	10,000 Reduced 6.18%	151,911 Common Stock
Dec 12 2023	BUY Exercise of conversion of derivative security	$129,400 $12.94 p/Share	10,000 Added 5.82%	161,911 Common Stock

MJL

Michael J. La Barre

SVP, CHIEF TECHNICAL OFFICER

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Value

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

Operation

Value

Type

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Track Activities on HALO

Account